Spry Health, a Silicon Valley company, won FDA clearance to introduce its…
Genetesis, a company based in Mason, Ohio, won FDA clearance for its cardiac imaging offering that combines the CardioFlux magnetocardiograph with the the integrated Faraday Analytical Cloud (FAC).
Fifth Eye, an Ann Arbor, Michigan-based startup, has raised an $11.5 million Series A funding round spearheaded by Arboretum Ventures and Cultivation Capital. MINTS (Michigan Investment in New Technology Startups), the direct investing arm of the University of Michigan’s endowment, also participated.
The Aktiia PulseWatch optical blood pressure monitor was tested in six healthy volunteers and agreed with a traditional inflating-cuff blood pressure monitor (Omron M6) two months after the initial calibration. The PulseWatch was accurate to within 1 ± 7 mmHg, which satisfied the 5±8 mmHg guidelines set by the AAMI (Association for the Advancement of Medical Instrumentation).
CytoSorbents (Monmouth Junction, N.J.) recently announced that it has received approval from the State of Israel Ministry of Health’s medical device regulation unit for its CytoSorb blood purification technology.
Ablation of cardiac tissue is one of the most common ways of treating atrial fibrillation. Interventional cardiologists have to work quite a bit to make sure the energy they’re delivering hits the correct areas. The HeartLight X3 System from CardioFocus is designed to make this process much faster and it has just been approved in the EU.
Pacemakers, defibrillators and other cardiac implants are life saving devices, but the batteries inside of them remain their Achilles’ heel. Every five to ten years they have to be replaced in another invasive surgery that patients abhor and that put a high cost on the healthcare system.